🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us for the next VIRTUAL educational event on 12/7/2022 6pm on CNS disease in #lungcancer! #LCSM

Excited to share the first paper from my lab. We show that condensates composed of the disordered region of MED1 selectively partition specific functionally related proteins from a complex mixture of biomolecules, regulating gene activation. Free link: authors.elsevier.com/a/1gMr6L7PXiqyW

Nice to see this in print. Cohort of patients with KRAS G12C NSCLC with untreated brain metastases prospectively enrolled and treated with adagrasib. Clear CNS activity. ascopubs.org/doi/full/10.12… Joshua Sabari, MD Journal of Clinical Oncology Shirish Gadgeel Jared Weiss Alex Spira, M.D.

Treating patients with KRAS-mutant lung cancer and untreated CNS metastasis with Adagrasib shows promising intracranial activity response, according to a Journal of Clinical Oncology trial update. #NSCLC Read early results, co-authored by Joshua Sabari, MD: bit.ly/3qZ111D

Our study of clinical/genomic predictors of response and toxicity to sotorasib in KRAS G12C+ NSCLC we recently presented at #ASCO23 is out today JCO Precision Oncology. Thanks to Gʀᴇɢᴏʀʏ Rɪᴇʟʏ Kathryn C. Arbour Benjamin Herzberg Joshua Sabari, MD for the mentorship and collaboration! ascopubs.org/doi/abs/10.120…

.Alex Spira, M.D. led a panel of experts to discuss current treatment options for patients with EGFR exon 20 non–small cell lung cancer. #NSCLC | Joshua Sabari, MD Misako Nagasaka Christine Bestvina Millie Das MD ow.ly/6N8w50PBEzG

⏰ NEW DEADLINE ALERT ⏰ Hurry, it's your final shot! Submit your abstract for #EGFRSummit by 9/11. SUBMIT HERE: ce.ceconcepts.com/EGFR23 Jill Feldman Ivy Elkins Zosia Piotrowska @egfrresisters Stephen V Liu, MD Helena Yu Joshua Sabari, MD Mary Jo Fidler Christine Lovly, MD, PhD, FASCO #EGFR #LCSM

Don’t miss it! Join us OncLive SOSS Lung Cancer Perlmutter Cancer Center at NYU Langone Health Vamsi Velcheti, MD MBA FASCO Elaine Shum Salman Punekar @sallylau @abrahamchachoua NYU Langone Health Thursday December 14th, 2023 6-9PM Martinique New York on Broadway, 49 W 32 St. event.onclive.com/event/7ee6555c…

Stay “cure-ious” Vamsi Velcheti, MD MBA FASCO. We NEED better perioperative approaches that will lead to more cures in our patients with early stage NSCLC. Two lung cancer Giants in the same shot. OncLive SOSS Perlmutter Cancer Center at NYU Langone Health

PALOMA-3 results Journal of Clinical Oncology after #ASCO24 oral presentation. Subcutaneous vs intravenous amivantamab (with lazertinib) in previously treated #EGFR NSCLC (n=418). Primary PK endpoint shows non-inferiority. Subcutaneous with much better safety profile. ascopubs.org/doi/10.1200/JC…

🚨24 Hours to go until Joshua Sabari, MD and Marcelo Negrao delve into the latest NSCLC data presented in Chicago! Calling all thoracic oncologists, surgeons and pulmonologists to join the LIVE discussion and earn CME credits! ⏰ Set a reminder here: ms.spr.ly/6017YoO7W

Lung Ca Highlights from #ASCO24 w/ Joshua Sabari, MD - #LAURA - #MARIPOSA+#PALOMA3 - #CROWN - #ADRIATIC Full 🗣️ - Oncbrothers.com/asco24-lung - targetedonc.com/data-dialogue-… - The “Oncology Brothers” podcast #lcsm ASCO #OncTwitter #MedTwitter Targeted Oncology Jill Feldman EGFR Resisters

What an amazing experience discussing practice changing lung cancer abstracts #ASCO24 with Oncology Brothers Perlmutter Cancer Center at NYU Langone Health NYUGSOM Hematology & Medical Oncology Fellowship NYU Langone Health

Our goal is to help early career investigators foster collaborations early in their careers and support their important work. YOU are our future. Please share with early investigators you know! Submit your abstract for the #EGFRSummit Don’t miss the the 9/30 deadline!

Excited to work with CURE as the new editor in chief! Thank you Debu Tripathy, MD for your vision. CURE magazine provides cutting edge advancements for patients with cancer, families and caregivers.Perlmutter Cancer Center at NYU Langone Health MD Anderson Cancer Center CURE Today curetoday.com/view/discussin…

Real World Data on Overall Survival in EGFR mutant NSCLC treated with first line Osimertinib Perlmutter Cancer Center at NYU Langone Health NYU Langone Health JTO & JTO CRR jto.org/article/S1556-…

Getting excited for ASCO 2025! Join us Sat, May 31 at The Sheraton Grand Chicago Riverwalk in Chicago 6 Ballroom for #PrecisionMedicine in #NSCLC at #ASCO25! 6:30 PM CDT Reg & Dinner | 7 PM CDTSymposium. PeerView LUNGevity Foundation Oncology Brothers ➡️ bit.ly/25TT-T

Join Joshua Sabari, MD (Joshua Sabari, MD), Jonathan W. Goldman, MD, Gilberto Lopes, MD, MBA, FASCO (gilberto lopes), Zosia Piotrowska, MD, MHS (Zosia Piotrowska) & Oncology Brothers, on 5/31 at 6:30 PM CDT during #ASCO25 for an #NSCLC #MedEd event. Produced w/ @Lungevity. bit.ly/25TT-T

📣 HCPs 📣 Do you treat pts w/ rare alterations of #NSCLC? Medical Oncologist Dr Joshua Sabari, MD and Debra Montague (President of @LungCancerEu/founder of UKALK+) share views on: ➡️The pt pathway ➡️#MedOnc vs Patient needs ➡️The support currently available Watch the video/listen on

Advancements Reshape Treatment for Non-Small Cell Lung Cancer Joshua Sabari, MD Perlmutter Cancer Center at NYU Langone Health Prantesh Jain MD, FACP Roswell Park #LungCancer curetoday.com/view/advanceme…